What is Biodesix, Inc.'s long term notes payable?

Biodesix, Inc. (BDSX) reported long term notes payable of $46.49M in Q1 2026.

How has Biodesix, Inc.'s long term notes payable changed year-over-year?

Biodesix, Inc.'s long term notes payable increased by 26.7% year-over-year, from $36.69M to $46.49M.

What is the long-term trend for Biodesix, Inc.'s long term notes payable?

Over 5 years (2020 to 2025), Biodesix, Inc.'s long term notes payable has grown at a 24.4% compound annual growth rate (CAGR), from $15.93M to $47.45M.

Biodesix, Inc. BDSX Long Term Notes Payable

Long Term Notes Payable at other companies

Highwoods PropertiesHIW

$3.7B+10.9%

Microvast Holdings, Inc.MVST

$52.26M+9.1%

Ring EnergyREI

$0—

Middlesex Water CompanyMSEX

$47M+38.2%

FuboTV FUBO

$4.6M-36.2%

Aebi Schmidt Holding AG Common StockAEBI

$58.21M—

Other financials

Income statement

See full

Revenue$25.6M+42.3%

Operating income-$6.2M+32.1%

Net income-$7.8M+29.8%

EPS (diluted)-$0.81+46.7%

Balance sheet

See full

Cash & equivalents$25.6M+45.3%

Total debt$71.6M+15.0%

Total equity$9.1M-17.4%

Total assets$94.6M+9.7%

Cash flow

See full

Operating cash flow-$10.2M-18.2%

CapEx$81.0K+9.5%

Free cash flow-$10.2M-18.1%

Valuation

See full

Market cap$233.52M+476%

Enterprise value$279.56M+204%

P/S2.4×+1.9×

Profitability

See full

Operating margin-26%-7.5pp

Net margin-33.3%-9.3pp

FCF margin-26.8%-9.6pp

Returns & leverage

See full

Return on equity-316.5%—

Debt / equity7.8×+2.2×

Current ratio2.8×+0.6×

Where this comes from

Reported directly by Biodesix, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LongTermNotesPayable.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s long term notes payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biodesix, Inc.'s long term notes payable?: Biodesix, Inc. (BDSX) reported long term notes payable of $46.49M in Q1 2026.
How has Biodesix, Inc.'s long term notes payable changed year-over-year?: Biodesix, Inc.'s long term notes payable increased by 26.7% year-over-year, from $36.69M to $46.49M.
What is the long-term trend for Biodesix, Inc.'s long term notes payable?: Over 5 years (2020 to 2025), Biodesix, Inc.'s long term notes payable has grown at a 24.4% compound annual growth rate (CAGR), from $15.93M to $47.45M.